Accueil > Actualité
Actualite financiere : Actualite bourse

AstraZeneca: FDA approves new lung cancer drug

( - US regulators have approved AstraZeneca's Tagrisso for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC), the drugmaker said on Thursday.

In a phase III trial, Tagrisso delivered "unprecedented" median progression-free survival of 18.9 months versus 10.2 months compared with current standard of care, the company said.

Its shares are almost flat at 4,959 pence in early morning trading in London today.

Copyright (c) 2018 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.